A Pharmacokinetics and Safety Study of Narfurine Hydrochloride Orally Disintegrating Tablets
Status:
Active, not recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
Main objective: To evaluate the pharmacokinetics of single and multiple oral administration
of narfurine hydrochloride orally disintegrating tablets in Chinese healthy adult subjects.
Secondary objective: To evaluate the safety profile of single and multiple oral
administration of narfurine hydrochloride orally disintegrating tablets in Chinese healthy
adult subjects.